Novel antifungal agents in clinical trials [version 2; peer review: 2 approved]

Invasive fungal diseases due to resistant yeasts and molds are an important and increasing public health threat, likely due to a growing population of immunosuppressed hosts, increases in antifungal resistance, and improvements in laboratory diagnostics. The significant morbidity and mortality asso...

Full description

Saved in:

Bibliographic Details
Published in:	F1000 research Vol. 10; p. 507
Main Authors:	Jacobs, Samantha E, Zagaliotis, Panagiotis, Walsh, Thomas J
Format:	Journal Article
Language:	English
Published:	England Faculty of 1000 Ltd 2022 F1000 Research Limited F1000 Research Ltd
Subjects:	Amphotericin B Antifungal Agents Antifungal Agents - pharmacology Antifungal Agents - therapeutic use Biosynthesis Clinical trials Drug dosages Drug interactions Drug Resistance, Fungal eng Enzymes Fungi Immunocompromised Host Meningitis Morbidity Neutropenia novel treatments Pathogens Pharmacodynamics pharmacokinetic and pharmacodynamic Pharmacokinetics Proteins Public health Review Antifungal Agents clinical trials pharmacokinetic and pharmacodynamic novel treatments
ISSN:	2046-1402, 2046-1402
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!